Research from Oklahoma State University Center for Health Sciences in the Area of Drug Development Described (Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials)

Media coverage

• Title	Research from Oklahoma State University Center for Health Sciences in the Area of Drug Development Described (Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials)
  Media name/outlet	Clinical Trials Daily
  Country/Territory	United States
  Date	11/06/24
  Persons	Matt Vassar, Griffin Hughes, William Nowlin